Advertisement

Virchows Archiv B

, Volume 59, Issue 1, pp 89–93 | Cite as

Mouse epidermal cell renewal after topical treatment with different concentrations of the epidermal peptide pyroGlu-Glu-Asp-Ser-GlyOH

  • Kjell Elgjo
  • Karl L. Reichelt
Article

Summary

Earlier work has shown that epidermal cells contain a peptide, pyroGlu-Glu-Asp-Ser-GlyOH, that induces a moderate but long-lasting inhibition of epidermal cell proliferation when given at low (picomol) doses ip in vivo and in vitro. In the present study, the epidermal pentapeptide was applied topically to the back skin of hairless mice at different concentrations and in a water-miscible cream. A single topical application of either high (0.25% wt/wt) or low (0.004% or 0.02% wt/ wt) doses of the pentapeptide was followed by oscillations in epidermal DNA synthesis and G2-M cell flux (mitotic rate). In general, epidermal cell proliferation was inhibited during the first 10-day period after treatment with the two lower doses, while the highest concentration of pentapeptide (0.25%) stimulated epidermal cell proliferation. In spite of the effects on epidermal cell proliferation the size of the epidermal cell population in the treated area (number of nucleated cells and epidermal thickness) showed no corresponding alterations. The results could imply that the epidermal pentapeptide modifies epidermal cell proliferation and terminal differentiation in such a way that the two are balance with each other.

Key words

Epidermis Growth regulation Peptide Inhibition 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brönstad GO, Sand T-E, Christoffersen T (1983) Bidirectional concentration-dependent effects of glucagon and dibutyryl cyclic AMP on DNA synthesis in cultured adult rat hepatocytes. Biochim Biophys Acta 763:58–63PubMedCrossRefGoogle Scholar
  2. Centrella M, McCarthy TL, Canalis E (1987) Transforming growth factor β is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal calf bone. J Biol Chem 262:2869–2874PubMedGoogle Scholar
  3. Christensen HN (1987) Why we might as well forget pyroglutamate as an amino acid. TIPS 9:430Google Scholar
  4. Clausen OPF, Thorud E, Bjerknes R, Elgjo K (1979) Circadian rhythms in mouse epidermal basal cell proliferation. Cell Tissue Kinet 12:319–337PubMedGoogle Scholar
  5. Datta HK, Zaidi M, Champaneri JB, MacIntyre I (1989) Transforming growth factor-β-induced mitogenesis of human bone cancer cells. Biochem Biophys Res Comm 161:672–676PubMedCrossRefGoogle Scholar
  6. Eigsti OJ, Dustin Pjr (1955) Colchicine in Agriculture, Medicine, Biology, and Chemistry. The Iowa College Press, AmesGoogle Scholar
  7. Elgjo K, Clausen OPF (1983) Proliferation-dependent effect of skin extracts (chalone) on mouse epidermal cell flux at the G1-S, S-G2, and G2 -M transitions. Virchows Arch [B] 42:143–151Google Scholar
  8. Elgjo K, Reichelt KL (1984) Purification and characterization of a mitosis inhibiting epidermal peptide. Cell Biol Int Rep 8:379–383PubMedCrossRefGoogle Scholar
  9. Elgjo K, Reichelt KL (1988) Structure and function of growth inhibitory epidermal pentapeptide. Ann NY Acad Sci 548:197–203PubMedCrossRefGoogle Scholar
  10. Elgjo K, Reichelt KL, Edminson P, Moen E (1986a) Endogenous peptides in epidermal growth control. Serono Symp Publ Raven Press 34:259–266Google Scholar
  11. Elgjo K, Reichelt KL, Hennings H, Michael D, Yuspa HS (1986b) Purified epidermal pentapeptide inhibits proliferation and enhances terminal differentiation in cultured mouse epidermal cells. J Invest Dermatol 87:555–558PubMedCrossRefGoogle Scholar
  12. Gardner MLG (1985) Production of pharmacologically active peptides from foods in the gut. In: Hunter JO, Alun Jones V (eds) Food and the Gut. Bailliere-Tindall, London, pp 121–134Google Scholar
  13. Iversen OH, Evensen A (1962) Experimental skin carcinogenesis in mice. Acta Pathol Microbiol Scand [Suppl] 156Google Scholar
  14. Masson MA, Moreau O, Debuire B (1979) Evidence for the resistance of thyrotropin-releasing hormone (TRH) and pseudohormone, pyroglutamyl histidyl amphetamine, to degradation enzymes in the digestive tract in vivo. Biochimie 61:852–874CrossRefGoogle Scholar
  15. Nome O (1975) Tissue specificity of the epidermal chalones. Virchows Arch [B] 19:1–25Google Scholar
  16. Nugent MA, Newman MJ (1989) Inhibition of normal rat kidney cell growth by transforming growth factor-β is mediated by collagen. J Biol Chem 264:18060–18067PubMedGoogle Scholar
  17. Olsen WM, Elgjo K (1990) UVB-induced epidermal hyperproliferation is partially inhibited by a single treatment with an endogenous epidermal pentapeptide. J Invest Dermatol 94:101–106PubMedCrossRefGoogle Scholar
  18. Paukovits WR, Elgjo K, Laerum OD (1990) Pentapeptide growth inhibitors. In: Sporn MB, Roberts AB (eds) Peptide growth factors and their receptors. Handbook of experimental pharmacology, vol 95 II. Springer, Berlin Heidelberg New York Tokyo, pp 268–295Google Scholar
  19. Reichelt KL, Elgjo K, Edminson P (1987) Isolation and structure of epidermal mitosis inhibiting pentapeptide. Biochem Biophys Res Comm 146:1493–1501PubMedCrossRefGoogle Scholar
  20. Tustin A (1955) Feedback. In: Automatic control. Simon and Schuster, New York, pp 10–32Google Scholar
  21. Watt FM, Reichelt KL, Elgjo K (1989) Pentapeptide inhibitor of epidermal mitosis: production and responsiveness in cultures of normal, transformed and neoplastic human keratinocytes. Carcinogenesis 10:2249–2253PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • Kjell Elgjo
    • 1
  • Karl L. Reichelt
    • 1
  1. 1.Institute of Pathology and Pediatric Research Institute, RikshospitaletOslo 1Norway

Personalised recommendations